Use access key #2 to skip to page content.
$39.58 3.08 (8.44%)
10/13/2008 4:03 PM

AstraZeneca plc (ADR) (AZN)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

View All Commentary (AZN)

Recs

0

Avatar mhheins (61.48) Submitted: 8/16/07 2:37 AM : Outperform Start Price: $43.17 AZN Score: 20.83

suspect, but tremendous potential for growth based in a pipeline that is ever expanding - one very large hurdle - size - they may be too big and need to spin off

Report this Post Replies: 0 | Reply

Featured Broker Partners